pocketful logo light
pocketful logo light
Nectar Lifescience Ltd logo

Nectar Lifescience Ltd

NSE: NECLIFE BSE: 532649

₹11.44

(1.63%)

Sat, 20 Jun 2026, 01:45 pm

Nectar Lifescience Share Price Live Chart

1 Day

(1.63%)

No Result Found

Summary

  • Market Cap (in Cr)

    241.47

  • Net Profit (in Cr)

    -113.68

  • P/B

    0.54

  • Sector P/E

    33.76

  • P/E

    0

  • EV/EBITDA

    0

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    -11.23

  • ROCE

    -5.33

  • Debt/Equity

    0.60

  • EPS (TTM)

    0

  • Dividend Yield

    0

  • Book Value

    36.75

  • Interest Cover

    -1.17

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters51.8444.9144.9144.5344.53
FII0.600.520.620.811.65
DII4.015.820.090.190.16
Public43.5248.7354.3754.4453.65
Government0.020.020.020.020.02

Read More

Technical Analysis

RSI

41.17

MACD

-0.17

50 DMA

12.20

200 DMA

14.24

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic19.3216.1814.3213.0411.189.906.76
Fibonacci16.1814.9814.2413.0411.8411.109.90
Camarilla13.3113.0312.7413.0412.1611.8711.59

Pivots Level: Classic

R3

+6.28

19.32

R2

+3.14

16.18

R1

+1.27

14.32

13.04
13.04
Pivot Point
LTP: 11.44

S1

-1.87

11.18

S2

-3.14

9.90

S3

-6.28

6.76

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    11.74

  • 20-EMA

    11.90

  • 30-EMA

    11.98

  • 50-EMA

    12.12

  • 100-EMA

    12.81

  • 200-EMA

    14.92

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
30 May 2026board-meetingsAccounts
23 Jan 2026board-meetingsQuarterly Results, Nine Months Results
03 Dec 2025buyback
24 Nov 2025buybackBuy Back of Shares24 Dec 2025
14 Nov 2025board-meetingsQuarterly Results
26 Aug 2025agm
07 Jul 2025egm
19 Aug 2024agm
13 Aug 2024agmAnnual General Meeting15 Sept 2024
14 Aug 2023agmAnnual General Meeting15 Sept 2023

Read More

Peer Comparison

Nectar Lifescience Ltd logo

Nectar Lifescience Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Nectar Lifescience Ltd About

Nectar Lifescience is engaged in promoting education and employment enhancing vocational skills among women to help them in earning their livelihood.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1995

Headquarters

CEO

Sanjiv Goyal

Employees

Contact

Website icon

Website

http://www.neclife.com

Email icon

Email

cs@neclife.com

Phone icon

Phone

91-1762-308000

Location icon

Location

Village Saidpura, Tehsil Derabassi S A S Nagar, Mohali, Punjab, 140507

Read More

Nectar Lifescience Ltd Company History

YearHistory
2012
  • NecLife granted Certificate of Suitability for Cefuroxime Sodium in European Union
  • The Company recommended a 10% Final Dividend
  • Mr Harparkash Singh Gill was appointed as a Wholetime Director designated as President Operation and Director
2013
  • Mr Dinesh Dua was appointed as an Additional Director and Wholetime Director designated as Chief Executive Officer
2014
  • Mr Sanjiv Goyal received the Outstanding Entrepreneurship of the Year award from Asia Pacific Enterprise Awards
  • NecLife received European cGMP Approval for its Orals and Injectables Cephalsporins FDF Facility
2015
  • Nectar Lifesciences Ltd was honoured with the NECA 2015 Award.
2019
  • Nectar Biopharma launched a generic diabetes treatment drug in India.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
JAIDEEP SAMPATbulkSell169574620.5404 Dec 2025
ANKITA VISHAL SHAHbulkSell134952520.6504 Dec 2025
QE SECURITIES LLPbulkSell126693320.3604 Dec 2025
IRAGE BROKING SERVICES LLPbulkSell147903320.4704 Dec 2025
MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITEDbulkBuy150000020.9304 Dec 2025
ANKITA VISHAL SHAHbulkBuy134952521.0104 Dec 2025
IRAGE BROKING SERVICES LLPbulkBuy80011220.4804 Dec 2025
RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITEDbulkBuy150000020.8704 Dec 2025
QE SECURITIES LLPbulkBuy118023920.604 Dec 2025
SHARE INDIA SECURITIES LIMITEDbulkSell138064120.2611 Jul 2025

Read More

Nectar Lifescience Ltd News

Nectar Lifesciences Board Meeting

Nectar Lifesciences board meets on May 30, 2026 to consider FY26 audited results.

25 May 2026

companies

Nectar Lifesciences Wins Income Tax Assessment Case

Nectar Lifesciences Limited receives favorable order from Deputy Commissioner of Income Tax, Chandigarh, disposing of assessment matter for AY 2017-18 with no financial implications.

29 Apr 2026

companies

Nectar Lifesciences extends capsule business sale deadline

Nectar Lifesciences Ltd. has extended the completion date for the slump sale of its Empty Hard Gelatin Capsule business to July 31, 2026, under Regulation 30 of SEBI regulations.

28 Apr 2026

companies

Nectar Lifesciences Launches Saksham Niveshak Campaign

Nectar Lifesciences initiated its second 100-day 'Saksham Niveshak' shareholder outreach campaign from April 01, 2026 to July 09, 2026, aimed at helping investors update KYC details and claim unpaid dividends.

08 Apr 2026

companies

Nectar Lifesciences Files Q4 FY26 Demat Compliance

Nectar Lifesciences Limited submitted its quarterly dematerialization compliance certificate for Q4 FY26 to stock exchanges, confirming adherence to SEBI regulations through registrar KFin Technologies.

06 Apr 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number